Robert Reder

Robert Reder has been working in the field of pharmacovigilance for over twenty years. Robert began their career at Purdue Pharma LP in 1992 as a VP of Clinical Development. In 2005, they moved to Endo Pharmaceuticals where they served as VP of Clinical Development, Medical Affairs, and Pharmacovigilance. In 2008, they joined Abbott as the Head of Postmarketing Safety Evaluation and Pharmacovigilance. Robert has been with AtlasMedx since 2012 and currently serves as an advisor.

Robert Reder's educational career began with him obtaining a Bachelor's degree from the University of Wisconsin-Madison. Robert then went on to obtain a Doctor of Medicine (M.D.) from Icahn School of Medicine at Mount Sinai.